Princeton OKs Unapproved Vaccine

In the wake of a seventh case of meningitis on Princeton University’s campus, officials announced Monday that a vaccine for the type B meningococcal bacteria will be available for students on campus starting in December. The vaccine, called Bexsero, was conditionally approved by the FDA on Monday, but the move itself was reportedly inspired by the Centers for Disease Control and Prevention. Meningitis causes the membranes surrounding the brain and spinal cord to swell, leading to mental disabilities, paralysis, and even death. The vaccines will not be mandatory.